Subscribe
Following a tricky second quarter, are market conditions favouring biotechs?
Portfolio Clinic: With sizeable assets, our reader wonders what else needs to be done as he considers an early retirement. Dave Baxter takes a look
A breathless rally has lifted plenty of portfolios
Visma鈥檚 listing is excellent news for London, but comes with complications for its private equity owners
What to look out for when picking a portfolio
Some of the sector鈥檚 top names are widening the net beyond London
Prioritising returns over yield, and businesses over contracts, this fund鈥檚 unique approach is paying off聽
After a brief interlude over the summer, Saba is renewing its focus on the investment trust sector and is working on a UK ETF
The move marks a win for RM Funds, but the activist is still pushing for bigger changes
A renewables trust鈥檚 turnaround plan brings to mind some familiar challenges
